Skip to main content

Santarus, Inc. (NASDAQ:SNTS) Investor Files Lawsuit Against Acquisition By Salix Pharmaceuticals

  • If you purchased shares of Santarus, Inc. (NASDAQ:SNTS) and currently hold any of those NASDAQ:SNTS shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

November 18, 2013 (Shareholders Foundation) - An investor, who currently hold shares of shares of Santarus, Inc. (NASDAQ:SNTS) filed a lawsuit in effort to halt the proposed takeover of Santarus, Inc. by Salix Pharmaceuticals, Ltd for $32.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:SNTS stockholders arising out of the attempt...

You must register (for free) or login to view the entire case.